|
J Biol Chem, Vol. 275, Issue 20, 14838-14845, May 19, 2000
Microtubule-interfering Agents Stimulate the Transcription of
Cyclooxygenase-2
EVIDENCE FOR INVOLVEMENT OF ERK1/2 AND p38 MITOGEN-ACTIVATED
PROTEIN KINASE PATHWAYS*
Kotha
Subbaramaiah §,
Janice C.
Hart ,
Larry
Norton¶, and
Andrew J.
Dannenberg
From the Department of Medicine, New York
Presbyterian Hospital-Cornell and Strang Cancer Prevention Center and
¶ Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer
Center, New York, New York 10021
We investigated whether microtubule-interfering
agents (MIAs: taxol, colchicine, nocodazole, vinblastine, vincristine,
17- -estradiol, 2-methoxyestradiol) altered cyclooxygenase-2 (COX-2)
expression in human mammary epithelial cells. MIAs enhanced
prostaglandin E2 synthesis and increased levels of
COX-2 protein and mRNA. Nuclear run-off assays revealed increased
rates of COX-2 transcription after treatment with MIAs.
Calphostin C, an inhibitor of protein kinase C, blocked the induction
of COX-2 by MIAs. The stimulation of COX-2 promoter
activity by MIAs was inhibited by overexpressing dominant negative
forms of Rho and Raf-1. MIAs stimulated ERK, JNK, and p38
mitogen-activated protein kinases (MAPK); pharmacological inhibitors of
MAPK kinase and p38 MAPK blocked the induction of COX-2 by MIAs.
Overexpressing dominant negative forms of ERK1 or p38 MAPK inhibited
MIA-mediated activation of the COX-2 promoter. MIAs
stimulated the binding of the activator protein-1 transcription factor
complex to the cyclic AMP response element in the COX-2 promoter. A dominant negative form of c-Jun inhibited the activation of
the COX-2 promoter by MIAs. Additionally, cytochalasin D,
an agent that inhibits actin polymerization, stimulated
COX-2 transcription by the same signaling pathway as MIAs.
Thus, microtubule- or actin-interfering agents stimulated MAPK
signaling and activator protein-1 activity. This led, in turn, to
induction of COX-2 gene expression via the cyclic AMP
response element site in the COX-2 promoter.
*
This work was supported in part by S/G 2P01 CA68425 and the
James E. Olson Memorial Fund.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: New York Presbyterian
Hospital-Cornell, Div. of Gastroenterology and Hepatology, Rm. F-203,
1300 York Ave., New York, NY 10021. Tel.: 212-746-4402; Fax:
212-746-4885; E-mail: ksubba@mail.med.cornell.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Zhang, L. Qiu, X. Jin, Z. Guo, and C. Guo
Nuclear Factor-{kappa}B Inhibition by Parthenolide Potentiates the Efficacy of Taxol in Non-Small Cell Lung Cancer In vitro and In vivo
Mol. Cancer Res.,
July 1, 2009;
7(7):
1139 - 1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. R. Healy, F. Zhu, J. D. Stull, and K. Konstantopoulos
Elucidation of the signaling network of COX-2 induction in sheared chondrocytes: COX-2 is induced via a Rac/MEKK1/MKK7/JNK2/c-Jun-C/EBP{beta}-dependent pathway
Am J Physiol Cell Physiol,
May 1, 2008;
294(5):
C1146 - C1157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Arany, B. K. Wagner, Y. Ma, J. Chinsomboon, D. Laznik, and B. M. Spiegelman
Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1{alpha} and oxidative phosphorylation
PNAS,
March 25, 2008;
105(12):
4721 - 4726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hohla, A. V. Schally, C. A. Kanashiro, S. Buchholz, B. Baker, C. Kannadka, A. Moder, E. Aigner, C. Datz, and G. Halmos
Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt
PNAS,
November 20, 2007;
104(47):
18671 - 18676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Mhaidat, R. F. Thorne, X. D. Zhang, and P. Hersey
Regulation of Docetaxel-Induced Apoptosis of Human Melanoma Cells by Different Isoforms of Protein Kinase C
Mol. Cancer Res.,
October 1, 2007;
5(10):
1073 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Azim, H. Cao, X. Gao, M. Joo, A. B. Malik, R. B. van Breemen, R. T. Sadikot, G. Park, and J. W. Christman
Regulation of cyclooxygenase-2 expression by small GTPase Rac2 in bone marrow macrophages
Am J Physiol Lung Cell Mol Physiol,
September 1, 2007;
293(3):
L668 - L673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Islam, C. J. Amuzie, J. R. Harkema, and J. J. Pestka
Neurotoxicity and Inflammation in the Nasal Airways of Mice Exposed to the Macrocyclic Trichothecene Mycotoxin Roridin A: Kinetics and Potentiation by Bacterial Lipopolysaccharide Coexposure
Toxicol. Sci.,
August 1, 2007;
98(2):
526 - 541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Xu and H.-K. G. Shu
EGFR Activation Results in Enhanced Cyclooxygenase-2 Expression through p38 Mitogen-Activated Protein Kinase-Dependent Activation of the Sp1/Sp3 Transcription Factors in Human Gliomas
Cancer Res.,
July 1, 2007;
67(13):
6121 - 6129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yano, T. Matsumura, T. Senokuchi, N. Ishii, Y. Murata, K. Taketa, H. Motoshima, T. Taguchi, K. Sonoda, D. Kukidome, et al.
Statins Activate Peroxisome Proliferator-Activated Receptor {gamma} Through Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase-Dependent Cyclooxygenase-2 Expression in Macrophages
Circ. Res.,
May 25, 2007;
100(10):
1442 - 1451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Mhaidat, X. D. Zhang, C. C. Jiang, and P. Hersey
Docetaxel-Induced Apoptosis of Human Melanoma Is Mediated by Activation of c-Jun NH2-Terminal Kinase and Inhibited by the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway
Clin. Cancer Res.,
February 15, 2007;
13(4):
1308 - 1314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zou, M. Adachi, K. Imai, M. Hareyama, K. Yoshioka, S. Zhao, and Y. Shinomura
2-Methoxyestradiol, an Endogenous Mammalian Metabolite, Radiosensitizes Colon Carcinoma Cells through c-Jun NH2-Terminal Kinase Activation.
Clin. Cancer Res.,
November 1, 2006;
12(21):
6532 - 6539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Csiki and D. H. Johnson
Did Targeted Therapy Fail Cyclooxygenase Too?
J. Clin. Oncol.,
October 20, 2006;
24(30):
4798 - 4800.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hirao, N. Tamai, N. Tsumaki, H. Yoshikawa, and A. Myoui
Oxygen Tension Regulates Chondrocyte Differentiation and Function during Endochondral Ossification
J. Biol. Chem.,
October 13, 2006;
281(41):
31079 - 31092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Hohla, A. V. Schally, K. Szepeshazi, J. L. Varga, S. Buchholz, F. Koster, E. Heinrich, G. Halmos, F. G. Rick, C. Kannadka, et al.
Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel
PNAS,
September 26, 2006;
103(39):
14513 - 14518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. V. Dantas and K. Sandberg
Does 2-Methoxyestradiol Represent the New and Improved Hormone Replacement Therapy for Atherosclerosis?
Circ. Res.,
August 4, 2006;
99(3):
234 - 237.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Barchiesi, E. K. Jackson, J. Fingerle, D. G. Gillespie, B. Odermatt, and R. K. Dubey
2-Methoxyestradiol, an Estradiol Metabolite, Inhibits Neointima Formation and Smooth Muscle Cell Growth via Double Blockade of the Cell Cycle
Circ. Res.,
August 4, 2006;
99(3):
266 - 274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Tang, A. Shih, H. J. Cao, F. B. Davis, P. J. Davis, and H.-Y. Lin
Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells.
Mol. Cancer Ther.,
August 1, 2006;
5(8):
2034 - 2042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. P. Croft and S. A. Przyborski
Formation of neurons by non-neural adult stem cells: potential mechanism implicates an artifact of growth in culture.
Stem Cells,
August 1, 2006;
24(8):
1841 - 1851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Wang, C.-Y. Ko, L.-C. Chen, W.-L. Wang, and W.-C. Chang
Functional role of NF-IL6{beta} and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene
Nucleic Acids Res.,
January 5, 2006;
34(1):
217 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Grishin, J. Wang, D. A. Potoka, D. J. Hackam, J. S. Upperman, P. Boyle, R. Zamora, and H. R. Ford
Lipopolysaccharide Induces Cyclooxygenase-2 in Intestinal Epithelium via a Noncanonical p38 MAPK Pathway
J. Immunol.,
January 1, 2006;
176(1):
580 - 588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Csiki, J. D. Morrow, A. Sandler, Y. Shyr, J. Oates, M. K. Williams, T. Dang, D. P. Carbone, and D. H. Johnson
Targeting Cyclooxygenase-2 in Recurrent Non-Small Cell Lung Cancer: A Phase II Trial of Celecoxib and Docetaxel
Clin. Cancer Res.,
September 15, 2005;
11(18):
6634 - 6640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, Y. Mao, P. W. Brandt-Rauf, A. C. Williams, and R. L. Fine
Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway
Mol. Cancer Ther.,
June 1, 2005;
4(6):
901 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Altorki, J. L. Port, F. Zhang, D. Golijanin, H. T. Thaler, A. J. Duffield-Lillico, K. Subbaramaiah, and A. J. Dannenberg
Chemotherapy Induces the Expression of Cyclooxygenase-2 in Non-Small Cell Lung Cancer
Clin. Cancer Res.,
June 1, 2005;
11(11):
4191 - 4197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Daikoku, D. Wang, S. Tranguch, J. D. Morrow, S. Orsulic, R. N. DuBois, and S. K. Dey
Cyclooxygenase-1 Is a Potential Target for Prevention and Treatment of Ovarian Epithelial Cancer
Cancer Res.,
May 1, 2005;
65(9):
3735 - 3744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Kim, I. A. Murray, A. M. Burns, F. J. Gonzalez, G. H. Perdew, and J. M. Peters
Peroxisome Proliferator-activated Receptor-{beta}/{delta} Inhibits Epidermal Cell Proliferation by Down-regulation of Kinase Activity
J. Biol. Chem.,
March 11, 2005;
280(10):
9519 - 9527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Gauthier, C. R. Pickering, C. J. Miller, C. A. Fordyce, K. L. Chew, H. K. Berman, and T. D. Tlsty
p38 Regulates Cyclooxygenase-2 in Human Mammary Epithelial Cells and Is Activated in Premalignant Tissue
Cancer Res.,
March 1, 2005;
65(5):
1792 - 1799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. W. Yim, H.-S. Jong, T. Y. Kim, H. H. Choi, S. G. Kim, S. H. Song, J. Kim, S.-G. Ko, J. W. Lee, T.-Y. Kim, et al.
Cyclooxygenase-2 Inhibits Novel Ginseng Metabolite-Mediated Apoptosis
Cancer Res.,
March 1, 2005;
65(5):
1952 - 1960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. V. Bava, V. T. Puliappadamba, A. Deepti, A. Nair, D. Karunagaran, and R. J. Anto
Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-{kappa}B and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization
J. Biol. Chem.,
February 25, 2005;
280(8):
6301 - 6308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Qian, K. J. Liu, Y. Chen, D. C. Flynn, V. Castranova, and X. Shi
Cdc42 Regulates Arsenic-induced NADPH Oxidase Activation and Cell Migration through Actin Filament Reorganization
J. Biol. Chem.,
February 4, 2005;
280(5):
3875 - 3884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-H. Kim, Y.-H. Kim, K.-J. Shin, Y.-S. Oh, C. S. Lee, K.-O. Kang, S. H. Ryu, and P.-G. Suh
2,2',4,6,6'-Pentachlorobiphenyl-Induced Apoptosis Is Limited by Cyclooxygenase-2 Induction
Toxicol. Sci.,
February 1, 2005;
83(2):
397 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-C. Wang, W.-N. Lin, C.-W. Lee, C.-C. Lin, S.-F. Luo, J.-S. Wang, and C.-M. Yang
Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-{kappa}B in IL-1{beta}-induced VCAM-1 expression in human tracheal smooth muscle cells
Am J Physiol Lung Cell Mol Physiol,
February 1, 2005;
288(2):
L227 - L237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zaric and C. Ruegg
Integrin-mediated Adhesion and Soluble Ligand Binding Stabilize COX-2 Protein Levels in Endothelial Cells by Inducing Expression and Preventing Degradation
J. Biol. Chem.,
January 14, 2005;
280(2):
1077 - 1085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Dannenberg, S. M. Lippman, J. R. Mann, K. Subbaramaiah, and R. N. DuBois
Cyclooxygenase-2 and Epidermal Growth Factor Receptor: Pharmacologic Targets for Chemoprevention
J. Clin. Oncol.,
January 10, 2005;
23(2):
254 - 266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sun and F. A. Sinicrope
Selective inhibitors of MEK1/ERK44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells
Mol. Cancer Ther.,
January 1, 2005;
4(1):
51 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hinz, R. Ramer, K. Eichele, U. Weinzierl, and K. Brune
Up-Regulation of Cyclooxygenase-2 Expression Is Involved in R(+)-Methanandamide-Induced Apoptotic Death of Human Neuroglioma Cells
Mol. Pharmacol.,
December 1, 2004;
66(6):
1643 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. A. Rossen, J. Bouma, R. H. C. Raatgeep, H. A. Buller, and A. W. C. Einerhand
Inhibition of Cyclooxygenase Activity Reduces Rotavirus Infection at a Postbinding Step
J. Virol.,
September 15, 2004;
78(18):
9721 - 9730.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Galindo, A. A. Fadl, J. Sha, C. Gutierrez Jr., V. L. Popov, I. Boldogh, B. B. Aggarwal, and A. K. Chopra
Aeromonas hydrophila Cytotoxic Enterotoxin Activates Mitogen-activated Protein Kinases and Induces Apoptosis in Murine Macrophages and Human Intestinal Epithelial Cells
J. Biol. Chem.,
September 3, 2004;
279(36):
37597 - 37612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sirois, K. Sayasith, K. A. Brown, A. E. Stock, N. Bouchard, and M. Dore
Cyclooxygenase-2 and its role in ovulation: a 2004 account
Hum. Reprod. Update,
September 1, 2004;
10(5):
373 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Biarc, I. S. Nguyen, A. Pini, F. Gosse, S. Richert, D. Thierse, A. Van Dorsselaer, E. Leize-Wagner, F. Raul, J.-P. Klein, et al.
Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis)
Carcinogenesis,
August 1, 2004;
25(8):
1477 - 1484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Brown and R. N. DuBois
Cyclooxygenase-2 in Lung Carcinogenesis and Chemoprevention: Roger S. Mitchell Lecture
Chest,
May 1, 2004;
125(5_suppl):
134S - 140S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Norvell, S. M. Ponik, D. K. Bowen, R. Gerard, and F. M. Pavalko
Fluid shear stress induction of COX-2 protein and prostaglandin release in cultured MC3T3-E1 osteoblasts does not require intact microfilaments or microtubules
J Appl Physiol,
March 1, 2004;
96(3):
957 - 966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Faisal, S. Kleiner, and Y. Nagamine
Non-redundant Role of Shc in Erk Activation by Cytoskeletal Reorganization
J. Biol. Chem.,
January 30, 2004;
279(5):
3202 - 3211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Zoubiane, A. Valentijn, E. T. Lowe, N. Akhtar, S. Bagley, A. P. Gilmore, and C. H. Streuli
A role for the cytoskeleton in prolactin-dependent mammary epithelial cell differentiation
J. Cell Sci.,
January 15, 2004;
117(2):
271 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Tessner, F. Muhale, S. Schloemann, S. M. Cohn, A. R. Morrison, and W. F. Stenson
Ionizing radiation up-regulates cyclooxygenase-2 in I407 cells through p38 mitogen-activated protein kinase
Carcinogenesis,
January 1, 2004;
25(1):
37 - 45.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ott, D. Iwanciw, A. Graness, K. Giehl, and M. Goppelt-Struebe
Modulation of the Expression of Connective Tissue Growth Factor by Alterations of the Cytoskeleton
J. Biol. Chem.,
November 7, 2003;
278(45):
44305 - 44311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-J. Kim, S.-G. Hwang, I.-C. Kim, and J.-S. Chun
Actin Cytoskeletal Architecture Regulates Nitric Oxide-induced Apoptosis, Dedifferentiation, and Cyclooxygenase-2 Expression in Articular Chondrocytes via Mitogen-activated Protein Kinase and Protein Kinase C Pathways
J. Biol. Chem.,
October 24, 2003;
278(43):
42448 - 42456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. De Lorenzo, K. Yamaguchi, K. Subbaramaiah, and A. J. Dannenberg
Bryostatin-1 Stimulates the Transcription of Cyclooxygenase-2: Evidence for an Activator Protein-1-Dependent Mechanism
Clin. Cancer Res.,
October 15, 2003;
9(13):
5036 - 5043.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Castelao, R. D. Bart III, C. A. DiPerna, E. M. Sievers, and R. M. Bremner
Lung cancer and cyclooxygenase-2
Ann. Thorac. Surg.,
October 1, 2003;
76(4):
1327 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Subbaramaiah, T. P. Marmo, D. A. Dixon, and A. J. Dannenberg
Regulation of Cyclooxgenase-2 mRNA Stability by Taxanes: EVIDENCE FOR INVOLVEMENT OF p38, MAPKAPK-2, and HuR
J. Biol. Chem.,
September 26, 2003;
278(39):
37637 - 37647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Dmitrovsky
Combining Cytotoxic Chemotherapy With Cyclooxygenase-2 Inhibition
J. Clin. Oncol.,
July 15, 2003;
21(14):
2631 - 2632.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.K. Altorki, R.S. Keresztes, J.L. Port, D.M. Libby, R.J. Korst, D.B. Flieder, C.A. Ferrara, D.F. Yankelevitz, K. Subbaramaiah, M.W. Pasmantier, et al.
Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non-Small-Cell Lung Cancer
J. Clin. Oncol.,
July 15, 2003;
21(14):
2645 - 2650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Reshkin, A. Bellizzi, R. A. Cardone, M. Tommasino, V. Casavola, and A. Paradiso
Paclitaxel Induces Apoptosis via Protein Kinase A- and p38 Mitogen-activated Protein-dependent Inhibition of the Na+/H+ Exchanger (NHE) NHE Isoform 1 in Human Breast Cancer Cells
Clin. Cancer Res.,
June 1, 2003;
9(6):
2366 - 2373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Shimada, M. Nakamura, E. Ishida, M. Kishi, and N. Konishi
Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis
Carcinogenesis,
June 1, 2003;
24(6):
1067 - 1075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. N. DuBois
Evaluation of the Whole Prostaglandin Biosynthetic Pathway in Lung Cancer
Clin. Cancer Res.,
May 1, 2003;
9(5):
1577 - 1578.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Deacon, P. Mistry, J. Chernoff, J. L. Blank, and R. Patel
p38 Mitogen-Activated Protein Kinase Mediates Cell Death and p21-Activated Kinase Mediates Cell Survival during Chemotherapeutic Drug-induced Mitotic Arrest
Mol. Biol. Cell,
May 1, 2003;
14(5):
2071 - 2087.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chauhan, G. Li, D. Auclair, T. Hideshima, P. Richardson, K. Podar, N. Mitsiades, C. Mitsiades, C. Li, R. S. Kim, et al.
Identification of genes regulated by 2-methoxyestradiol (2ME2) in multiple myeloma cells using oligonucleotide arrays
Blood,
May 1, 2003;
101(9):
3606 - 3614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Giuliano
High-Content Profiling of Drug-Drug Interactions: Cellular Targets Involved in the Modulation of Microtubule Drug Action by the Antifungal Ketoconazole
J Biomol Screen,
April 1, 2003;
8(2):
125 - 135.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Milne and H. N. Jabbour
Prostaglandin (PG) F2{alpha} Receptor Expression and Signaling in Human Endometrium: Role of PGF2{alpha} in Epithelial Cell Proliferation
J. Clin. Endocrinol. Metab.,
April 1, 2003;
88(4):
1825 - 1832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Gupta, L. V. Tejada, B. J. Tong, S. K. Das, J. D. Morrow, S. K. Dey, and R. N. DuBois
Cyclooxygenase-1 is Overexpressed and Promotes Angiogenic Growth Factor Production in Ovarian Cancer
Cancer Res.,
March 1, 2003;
63(5):
906 - 911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. Jung, J. S. Isaacs, S. Lee, J. Trepel, and L. Neckers
Microtubule Disruption Utilizes an NFkappa B-dependent Pathway to Stabilize HIF-1alpha Protein
J. Biol. Chem.,
February 21, 2003;
278(9):
7445 - 7452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Tessner, F. Muhale, S. Schloemann, S. M. Cohn, A. Morrison, and W. F. Stenson
Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase
Am J Physiol Gastrointest Liver Physiol,
February 1, 2003;
284(2):
G269 - G279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H. Yoo, M. P. Piechocki, J. F. Ensley, T. Nguyen, J. Oliver, H. Meng, D. Kewson, T. Y. Shibuya, F. Lonardo, and M. A. Tainsky
Docetaxel Induced Gene Expression Patterns in Head and Neck Squamous Cell Carcinoma Using cDNA Microarray and PowerBlot
Clin. Cancer Res.,
December 1, 2002;
8(12):
3910 - 3921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Monick, P. K. Robeff, N. S. Butler, D. M. Flaherty, A. B. Carter, M. W. Peterson, and G. W. Hunninghake
Phosphatidylinositol 3-Kinase Activity Negatively Regulates Stability of Cyclooxygenase 2 mRNA
J. Biol. Chem.,
August 30, 2002;
277(36):
32992 - 33000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Han, S. Tsui, and T. J. Smith
Up-regulation of Prostaglandin E2 Synthesis by Interleukin-1beta in Human Orbital Fibroblasts Involves Coordinate Induction of Prostaglandin-Endoperoxide H Synthase-2 and Glutathione-dependent Prostaglandin E2 Synthase Expression
J. Biol. Chem.,
May 3, 2002;
277(19):
16355 - 16364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Cassidy, P. J. Moos, R. C. Kelly, and F. A. Fitzpatrick
Cyclooxygenase-2 Induction by Paclitaxel, Docetaxel, and Taxane Analogues in Human Monocytes and Murine Macrophages: Structure-Activity Relationships and Their Implications
Clin. Cancer Res.,
March 1, 2002;
8(3):
846 - 855.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Samarakoon and P. J. Higgins
MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks
J. Cell Sci.,
January 8, 2002;
115(15):
3093 - 3103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Sawyer, S. M. Norvell, S. M. Ponik, and F. M. Pavalko
Regulation of PGE2 and PGI2 release from human umbilical vein endothelial cells by actin cytoskeleton
Am J Physiol Cell Physiol,
September 1, 2001;
281(3):
C1038 - C1045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. HALLSWORTH, L. M. MOIR, D. LAI, and S. J. HIRST
Inhibitors of Mitogen-activated Protein Kinases Differentially Regulate Eosinophil-activating Cytokine Release from Human Airway Smooth Muscle
Am. J. Respir. Crit. Care Med.,
August 15, 2001;
164(4):
688 - 697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Jorquera and R. M. Tanguay
Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability
Hum. Mol. Genet.,
August 1, 2001;
10(17):
1741 - 1752.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hyun Song, H.-S. Jong, H. H. Choi, H. Inoue, T. Tanabe, N. K. Kim, and Y.-J. Bang
Transcriptional Silencing of Cyclooxygenase-2 by Hyper-methylation of the 5' CpG Island in Human Gastric Carcinoma Cells
Cancer Res.,
June 1, 2001;
61(11):
4628 - 4635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bourgarel-Rey, S. Vallee, O. Rimet, S. Champion, D. Braguer, A. Desobry, C. Briand, and Y. Barra
Involvement of Nuclear Factor kappa B in c-Myc Induction by Tubulin Polymerization Inhibitors
Mol. Pharmacol.,
April 16, 2001;
59(5):
1165 - 1170.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. Subbarayan, A. L. Sabichi, N. Llansa, S. M. Lippman, and D. G. Menter
Differential Expression of Cyclooxygenase-2 and Its Regulation by Tumor Necrosis Factor-{{alpha}} in Normal and Malignant Prostate Cells
Cancer Res.,
March 1, 2001;
61(6):
2720 - 2726.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Kulkarni, J. S. Rader, F. Zhang, H. Liapis, A. T. Koki, J. L. Masferrer, K. Subbaramaiah, and A. J. Dannenberg
Cyclooxygenase-2 Is Overexpressed in Human Cervical Cancer
Clin. Cancer Res.,
February 1, 2001;
7(2):
429 - 434.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Subbaramaiah, D. T. Lin, J. C. Hart, and A. J. Dannenberg
Peroxisome Proliferator-activated Receptor gamma Ligands Suppress the Transcriptional Activation of Cyclooxygenase-2. EVIDENCE FOR INVOLVEMENT OF ACTIVATOR PROTEIN-1 AND CREB-BINDING PROTEIN/p300
J. Biol. Chem.,
April 6, 2001;
276(15):
12440 - 12448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-i. Okano and A. K. Rustgi
Paclitaxel Induces Prolonged Activation of the Ras/MEK/ERK Pathway Independently of Activating the Programmed Cell Death Machinery
J. Biol. Chem.,
May 25, 2001;
276(22):
19555 - 19564.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. de Gregorio, M. A. Iniguez, M. Fresno, and S. Alemany
Cot Kinase Induces Cyclooxygenase-2 Expression in T Cells through Activation of the Nuclear Factor of Activated T Cells
J. Biol. Chem.,
July 13, 2001;
276(29):
27003 - 27009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guzman-Verri, E. Chaves-Olarte, C. von Eichel-Streiber, I. Lopez-Goni, M. Thelestam, S. Arvidson, J.-P. Gorvel, and E. Moreno
GTPases of the Rho Subfamily Are Required for Brucella abortus Internalization in Nonprofessional Phagocytes. DIRECT ACTIVATION OF Cdc42
J. Biol. Chem.,
November 21, 2001;
276(48):
44435 - 44443.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|